Our team firstly reported that ECHDC3 was upregulated in CD34+ progenitors of chemoresistant AML (8), whereas the prognostic significance and function of ECHDC3 in AML have yet to be clarified. The gene discussed is CD34; the disease is acute myeloid leukemia.